Talle M, Doubell A, Robbertse P, Lahri S, Herbst P
J Cardiovasc Dev Dis. 2023; 10(9).
PMID: 37754796
PMC: 10532285.
DOI: 10.3390/jcdd10090367.
Kang S, Kwon Y
J Cardiovasc Imaging. 2019; 26(4):201-213.
PMID: 30607387
PMC: 6310760.
DOI: 10.4250/jcvi.2018.26.e26.
Fields L, Koschinski A, Zaccolo M
Cell Signal. 2015; 28(7):725-32.
PMID: 26475678
PMC: 4872538.
DOI: 10.1016/j.cellsig.2015.10.003.
Hinderliter A, Light K, Girdler S, Willis P, Sherwood A
Ann Behav Med. 2013; 18(1):61-6.
PMID: 24203645
DOI: 10.1007/BF02903941.
Koshman Y, Piano M, Russell B, Schwertz D
J Appl Physiol (1985). 2010; 108(3):686-96.
PMID: 20044473
PMC: 2838630.
DOI: 10.1152/japplphysiol.00994.2009.
Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.
OConnell T, Swigart P, Rodrigo M, Ishizaka S, Joho S, Turnbull L
J Clin Invest. 2006; 116(4):1005-15.
PMID: 16585965
PMC: 1421341.
DOI: 10.1172/JCI22811.
Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.
Turner L, Premo D, Gibbs B, Hearthway M, Motsko M, Sappington A
BMC Physiol. 2002; 2:1.
PMID: 11818034
PMC: 65049.
DOI: 10.1186/1472-6793-2-1.
The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure.
Lombardi W, Gilbert E
Curr Cardiol Rep. 2000; 2(2):90-8.
PMID: 10980878
DOI: 10.1007/s11886-000-0004-7.
Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice.
Saadane N, Alpert L, Chalifour L
Br J Pharmacol. 1999; 127(5):1165-76.
PMID: 10455263
PMC: 1566134.
DOI: 10.1038/sj.bjp.0702676.
Cardiac hypertrophy: old concepts, new perspectives.
Gupta M, Gupta M
Mol Cell Biochem. 1997; 176(1-2):273-9.
PMID: 9406172
Catecholamines and cardiac growth.
Gupta M, Gupta M, Jakovcic S, Zak R
Mol Cell Biochem. 1996; 163-164:203-10.
PMID: 8974058
DOI: 10.1007/BF00408659.
Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.
Ostman-Smith I
Br J Pharmacol. 1995; 116(6):2703-9.
PMID: 8590993
PMC: 1909123.
DOI: 10.1111/j.1476-5381.1995.tb17230.x.
Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.
Ostman-Smith I
Br J Pharmacol. 1995; 116(6):2698-702.
PMID: 8590992
PMC: 1909150.
DOI: 10.1111/j.1476-5381.1995.tb17229.x.
Repeated normoxic hyperbaric exposures induce haemodynamic and myocardial changes in rats.
Stuhr L, Bergo G, Skei S, Maehle B, Tyssebotn I
Eur J Appl Physiol Occup Physiol. 1993; 66(3):226-34.
PMID: 8477678
DOI: 10.1007/BF00235098.
Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative.
Mervaala E, Laakso J, Vapaatalo H, Karppanen H
Br J Pharmacol. 1994; 112(2):640-8.
PMID: 8075882
PMC: 1910381.
DOI: 10.1111/j.1476-5381.1994.tb13123.x.
Salt intake, blood pressure, and cardiovascular structure.
Beil A, Schmieder R, Messerli F
Cardiovasc Drugs Ther. 1994; 8(3):425-32.
PMID: 7947357
DOI: 10.1007/BF00877918.
Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine.
Ferrara L, De Simone G, Mancini M, Fasano M, Pasanisi F, Vallone G
Eur J Clin Pharmacol. 1984; 27(5):525-8.
PMID: 6394350
DOI: 10.1007/BF00556886.
Hypoxia-induced cardiac hypertrophy in rabbits treated with verapamil and nifedipine.
Dukes I, VAUGHAN WILLIAMS E
Br J Pharmacol. 1983; 80(2):241-7.
PMID: 6228279
PMC: 2045028.
DOI: 10.1111/j.1476-5381.1983.tb10026.x.
Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.
Simpson P
J Clin Invest. 1983; 72(2):732-8.
PMID: 6135712
PMC: 1129233.
DOI: 10.1172/JCI111023.
Hemodynamic versus adrenergic control of cat right ventricular hypertrophy.
Cooper 4th G, Kent R, Uboh C, Thompson E, Marino T
J Clin Invest. 1985; 75(5):1403-14.
PMID: 3158672
PMC: 425477.
DOI: 10.1172/JCI111842.
